Human Saga

CRISPR-Cas9 gene editing

June 2012·Science, technology & invention·Global·
June 2012Date
Science, technology & inventionCategory
0Empires active
Date
June 2012
Category
Science, technology & invention
Region
Global
Era
Contemporary
Significance

In a paper published in the journal Science in June 2012, Jennifer Doudna of the University of California, Berkeley, and Emmanuelle Charpentier, then at Umeå University in Sweden, with colleagues including Martin Jinek, showed that the bacterial CRISPR-Cas9 system could be reprogrammed as a precise, programmable tool to cut DNA at any chosen location.

Adapted from a natural immune mechanism that bacteria use against viruses, CRISPR-Cas9 made genome editing far cheaper, faster and easier than previous methods, allowing researchers to add, remove or alter genetic sequences with relative simplicity. The technology spread rapidly through laboratories worldwide and is being applied to agriculture, basic research and the treatment of genetic diseases, including the first approved CRISPR-based therapies for sickle-cell disease. Doudna and Charpentier received the 2020 Nobel Prize in Chemistry. The power of the tool also raised profound ethical questions, particularly about editing the human germline, which crystallised in later controversy. CRISPR is widely regarded as one of the most consequential biotechnologies of the twenty-first century.

See the world map in June 2012 →More science, technology & inventionThe Contemporary era

One piece of history in your inbox, weekly

New empires, events and features as they land — one good email a week. No spam, unsubscribe anytime.

Related science, technology & invention events

Further reading

As an Amazon Associate, Human Saga earns from qualifying purchases.